Skip to main content
SpringerLink
Log in

Antiepileptika (Antikonvulsiva)

  • Chapter
Neuro-Psychopharmaka im Kindes- und Jugendalter

  • 4705 Accesses

Zusammenfassung

Antiepileptika (synonym Antikonvulsiva) sind Neuro-Psychopharmaka zur symptomatischen Behandlung der verschiedenen Epilepsieformen, die unter Umständen lebenslang eingenommen werden müssen. Die Ziele der Behandlung von epileptischen Patienten mit Antiepileptika sind Anfallsfreiheit und möglichst wenige unerwünschte Arzneimittelwirkungen (UAWs) der medikamentösen Therapie. Ein ideales Antiepileptikum erhöht die Krampfschwelle, ohne die normale motorische Erregbarkeit zu beeinflussen. Antiepileptika heilen die Epilepsie nicht, können aber zu einer weitgehenden oder völligen Aufhebung der klinischen Symptomatik führen und dem Patienten ein normales Leben ermöglichen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis B.2.6.1. Weiterführende Lehrbücher

  • Aktories K, Förstermann U, Hofmann FB, Starke K (Hrsg) (2005) Allgemeine und spezielle Pharmakologie und Toxikologie, 9. Aufl. Urban & Fischer, München Jena

    Google Scholar 

  • Doose H (1998) (Hrsg) Epilepsien im Kindes-und Jugendalter, 11. Aufl. Harry und Jung GmbH, Flensburg

    Google Scholar 

  • Levy RH, Mattson RH Meldrum BS (eds) (2002) Antiepileptic drugs, Fifth edn. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Mutschler E, Geisslinger G, Kroemer HK, Ruth P, Schäfer-Korting M (Hrsg) (2008) Mutschler Arzneimittelwirkungen. Lehrbuch der Pharmakologie und Toxikologie, 9. völlig neu bearb. und erw. Aufl. Wissenschaftliche Verlagsgesellschaft, Stuttgart

    Google Scholar 

  • Riederer P, Laux G (Hrsg) (2006) Neuro-Psychopharmaka Bd. 6, Notfalltherapie, Antiepileptika, Psychostimulantien, Suchttherapeutika und sonstige Psychopharmaka, 2. Aufl. Springer, Wien New York

    Google Scholar 

  • Siemes H, Bourgeois BFD (2001) (Hrsg) Anfälle und Epilepsien bei Kindern und Jugendlichen. Thieme, Stuttgart New York

    Google Scholar 

  • Schmidt D, Elger CE (2005) (Hrsg) Praktische Epilepsiebehandlung, 2. überarb. Aufl. Thieme, Stuttgart New York

    Google Scholar 

Ausgewählte Literatur

  • Anhut H, Ashman P, Feuerstein TJ, Sauermann W, Saunders M, Schmidt B (1994) Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: A double-blind, placebo-controlled study. Epilepsia 35: 795–801

    Article  PubMed  CAS  Google Scholar 

  • Appleton RE, Peters AC, Mumford JP, Shaw DE (1999) Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 40: 1627–1633

    Article  PubMed  CAS  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2003) „Aus der UAW-Datenbank“ Hypothermie als reversible Nebenwirkung der Valproinsäure, Deutsches Ärzteblatt 100:A-871/B-735/C-687

    Google Scholar 

  • Benedetti MS (2000) Enzyme induction and inhibition by new antiepileptic drugs: a review of human studies. Fund Clin Pharmacol 14:301–319

    Article  CAS  Google Scholar 

  • Beydoun A, Nasreddine W, Atweh S (2008) Efficacy and tolerability of pregabalin in partial epilepsy. Expert Rev Neurother 8: 1013–1024

    Article  PubMed  CAS  Google Scholar 

  • Bleich A, Gelkopf M, Weizman T, Adelson M (2002) Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach. Israel J Psychiatry Rel Sci 39: 104–112

    Google Scholar 

  • Brodie MJ (2006) Zonisamide as adiunctive therapy for refractory partial seizures. Epilepsy Res 68 [Suppl 2]: 11–16

    Article  CAS  Google Scholar 

  • Canadian Study Group for Childhood Epilepsy (1998) Clobazam has equivalent efficacy to carbamazepine and phenytoin as monotherapy for childhood epilepsy: Canadian Study Group for Childhood Epilepsy. Epilepsia 39: 952–959

    Article  Google Scholar 

  • Crawford P, Meinardi H, Brown S, Rentmeester TW, Pedersen B, Pedersen PC, Lassen LC (2001) Tiagabine: efficacy and safety in adjunctive treatment of partial seizures. Epilepsia 42: 531–538

    Article  PubMed  CAS  Google Scholar 

  • Dulac O, Figueroa D, Rey E, Arthuis M (1983) Monotherapy with clobazam in epilepsies in children. Presse Med 12: 1067–1069

    PubMed  CAS  Google Scholar 

  • Elger ChE, Bauer J (2006) Antiepileptika. Definition, Einteilung, Chemie. In: Riederer P, Laux G (Hrsg) Neuro-Psychopharmaka Bd. 6, Notfall-therapie, Antiepileptika, Psychostimulantien, Suchttherapeutika und sonstige Psychopharmaka, 2. Aufl. Springer, Wien New York, 103–105

    Google Scholar 

  • Ernst JP, Steinhoff B (2007) Vademecum Antiepilepticum 2007/2008, Pharmakotherapie der Epilepsien. Deutsche Gesellschaft für Epileptologie — Deutsche Sektion der Internationalen Liga gegen Epilepsie (Hrsg) Vademecum Antiepileptikum, 19. überarb. Aufl. Desitin Arzneimittel GmbH, Hamburg

    Google Scholar 

  • Glauser TA, Pellock JM (2002) Zonisamide in pediatric epilepsy: review of the Japanese experience. J Child Neurol 17: 87–96

    Article  PubMed  Google Scholar 

  • Glauser T, Ben-Menachem E, Bourgeois B, Cnaan A, Chadwick D, Guerreiro C, Kalviainen R, Mattson R, Perucca E, Tomson T (2006a) ILAE treatment guidelines: Evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47: 1094–1120

    Article  PubMed  Google Scholar 

  • Glauser TA, Ayala R, Elterman RD, Mitchell WG, Van Orman CB, Gauer LJ, Lu Z, N159 Study Group (2006b) Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66: 1654–1660

    Article  PubMed  CAS  Google Scholar 

  • Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S (2008) Rufinamide for generalized seizures associated with Lennox-Gastaut syndrome. Neurology 70: 1950–1958

    Article  PubMed  CAS  Google Scholar 

  • Guerreiro MM, Vigonius U, Pohlmann H, de Manreza ML, Fejerman N, Antoniuk SA, Moore A (1997) A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy. Epilepsy Res 27: 205–213

    Article  PubMed  CAS  Google Scholar 

  • Hancock E, Cross H (2003) Treatment of Lennox-Gastaut syndrome. Cochrane Database Syst Rev 3: CD003277

    PubMed  Google Scholar 

  • Hussein G, Troupin AS, Montouris G (1996) Gabapentin interaction with felbamat, Neurology 47: 1106–1107

    PubMed  CAS  Google Scholar 

  • Jalil P (1992) Toxic reaction following the combined administration of fluoxetine and phenytoin: two cases reports. J Neurol Neurosurg Psychiatry 55: 412–413

    Article  PubMed  CAS  Google Scholar 

  • Jensen PK (1994) Felbamate in the treatment of Lennox-Gastaut Syndrome. Epilepsia 35 [Suppl 5]: 54–57

    Article  Google Scholar 

  • Kramer U, Shahar E, Zelnik N, Lerman-Sagie T, Watemberg N, Nevo Y, Ben-Zeev B (2002) Carbamazepine versus sulthiame in treating benign childhood epilepsy with centrotemporal spikes. J Child Neurol 17: 914–916

    PubMed  Google Scholar 

  • Krämer G (2000) Epilepsie: Antworten auf die häufigsten Fragen. TRIAS, Stuttgart

    Google Scholar 

  • Krief P, Li Kan, Maytal J (2008) Efficacy of levetiracetam in children with epilepsy younger than 2 years of age. J Child Neurol 23: 582–584

    Article  PubMed  Google Scholar 

  • LaRoche SM (2007) A new look at the second-generation antiepileptic drugs: a decade of experience. Neurologist 13: 133–139

    Article  PubMed  Google Scholar 

  • Löscher W (2006a) Antiepileptika. Experimentelle und klinische Pharmakologie. In: Riederer P, Laux G (Hrsg) Neuro-Psychopharmaka Bd. 6, Notfalltherapie, Antiepileptika, Psychostimulantien, Suchttherapeutika und sonstige Psychopharmaka, 2. Aufl. Springer, Wien New York, 127–135

    Google Scholar 

  • Löscher W (2006b) Antiepileptika. Neurobiochemie, Wirkmechanismen. In: Riederer P, Laux G (Hrsg) Neuro-Psychopharmaka Bd. 6, Notfall-therapie, Antiepileptika, Psychostimulantien, Suchttherapeutika und sonstige Psychopharmaka, 2. Aufl. Springer, Wien New York, 136–143

    Google Scholar 

  • Löscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation. Epilepsy Res 17: 95–134

    Article  PubMed  Google Scholar 

  • Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR (2007) A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial. Health Technology Assessment 11: iii–iv, ix–x, 1–134

    PubMed  CAS  Google Scholar 

  • McDonald DGM, Najam Y, Keegan MB, Whooley M, Madden D, McMenamin JB (2005) The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood. Seizure 14: 112–116

    Article  PubMed  CAS  Google Scholar 

  • McGee JH (1998) Acute, subchronic, and chronic toxicity studies with felbamate, 2-phenyl-1,3-propanediol dicarbamate. Tox Sci 45: 225–232

    Article  CAS  Google Scholar 

  • Michelucci R, Tassinari CA (1989) Response to vigabatrin in relation to seizure type. Brit J Clin Pharmacol 27 [Suppl 1]: 119–124

    Google Scholar 

  • Mikati MA, Lepejian GA, Holmes GL (2002) Medical treatment of patients with infantile spasms. Clin Neuropharmacol 25: 61–70

    Article  PubMed  CAS  Google Scholar 

  • Motamedi M, Nguyen DK, Zaatreh M, Singh SP, Westerveld M, Thompson JL, Mattson R, Blumenfeld H, Novotny E, Spencer SS (2003) Levetiracetam efficacy in refractory partial-onset seizures, especially after failed epilepsy surgery. Epilepsia 44: 211–214

    Article  PubMed  CAS  Google Scholar 

  • Mumford JP, Dam M (1989) Meta-analysis of European placebo controlled studies of vigabatrin in drug resistant epilepsy. Br J Clin Pharmacol 27 [Suppl 1]: 101–107

    Google Scholar 

  • Mullens EL (1998) Clinical experience with lamotrigine monotherapy in adults with newly diagnosed epilepsy: a review of published randomised clinical trials. Clin Drug Invest 16: 125–33

    Article  CAS  Google Scholar 

  • Noachtar S, Andermann E, Meyvisch P, Andermann F, Gough WB, Schiemann-Delgado J, N166 Levetiracetam Study Group (2008) Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 70: 607–616

    Article  PubMed  CAS  Google Scholar 

  • Otoul C, DeSmedt H, Stockis A (2007) Lack of pharmacokinetic interaction of levetiracetam on narbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia 48: 2111–2115

    Article  PubMed  CAS  Google Scholar 

  • Perry S, Holt P, Benatar M (2008) Levetiracetam versus carbamazepine monotherapy for partial epilepsy in children less than 16 years of age. J Child Neurol 23: 515–519

    Article  PubMed  Google Scholar 

  • Rating D, Wolf C, Bast T (2000) Sulthiame as monotherapy in children with benign childhood epilepsy with centrotemporal spikes: A 6-month randomized, double-blind, placebo-controlled study. Epilepsia 41: 1284–1288

    Article  PubMed  CAS  Google Scholar 

  • Sackellares JC, Ramsay RE, Wilder BJ, Browne TR, Shellenberger MK (2004) Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures. Epilepsia 45: 610–617

    Article  PubMed  CAS  Google Scholar 

  • Saetre E, Perucca E, Isojärvi J, Gjerstad L; LAM 40089 Study Group (2007) An international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 48: 1292–1302

    Article  PubMed  CAS  Google Scholar 

  • Schaffer LC, Schaffer CB, Caretto J (1999) The use of primidone in the treatment of refractory bipolar disorder. Ann Clin Psychiatry 11: 61–66

    PubMed  CAS  Google Scholar 

  • Schmidt D, Elger CE (2004) Worin unterscheidet sich Oxcarbazepin von Carbamazepin? Nervenarzt 75: 153–160

    Article  PubMed  CAS  Google Scholar 

  • Shinnar S, Pellock JM, Conry JA (2008) Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. Eur J Paed Neurol doi: 10.1016/j.ejpn.2008.01.004

    Google Scholar 

  • Sills G, Brodie M (2007) Pharmacokinetics and drug interactions with zonisamide. Epilepsia 48: 435–441

    Article  PubMed  CAS  Google Scholar 

  • Snead OC, Hosey LC (1985) Exacerbation of seizures in children by carbamazepine. N Engl J Med 313: 916–921

    Article  PubMed  Google Scholar 

  • Stefan H, Feuerstein TJ (2007) Novel anticonvulsant drugs. Pharmacol Therapy 113: 165–183

    Article  CAS  Google Scholar 

  • The US Gabapentin Study Group No. 5 (2001) Gabapentin as add-on therapy in refractory partial epilepsy: A double-blind, placebo-controlled, parallel-group study, 1993. Neurology 57 [Suppl 4]: 62–68

    Google Scholar 

  • Thomé-Souza S, Freitas A, Fiore L, Valente KD (2003) Lamotrigine and valproate: efficacy of co-administration in a pediatric population. Ped Neurol 28: 360–364

    Article  Google Scholar 

  • Valencia I, Pinol-Ripoll G, Khurana DS, Hardison HH, Kothare SV, Melvin JJ, Marks HG, Legido A (2008) Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy. Eur J Paed Neurol doi: 10.1016/j.ejpn.2008.03.002

    Google Scholar 

  • Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D (2007) Treatment of pediatric epilepsy: European expert opinion. Epilep Disord 9: 353–412

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Oberarzt der Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie, Universität Würzburg, Füchsleinstraße 15, 97080, Würzburg

    Dr. med. M. Romanos MD & T. Renner

  2. Arzt für Kinder- und Jugendpsychiatrie, Kapellenstraße 12, 97688, Bad Kissingen

    Dr. med. M. S. Kerdar

  3. Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Julius-Maximilians-Universität, Füchsleinstraße 15, 97080, Würzburg

    Prof. Dr. med. M. Gerlach

Authors
  1. Dr. med. M. Romanos MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dr. med. M. S. Kerdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Renner
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Prof. Dr. med. M. Gerlach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik und Poliklinik für Kinder- und Jugendpsychiatrie, Würzburg, Deutschland

    Manfred Gerlach  & Andreas Warnke  & 

  2. Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie, Universität Ulm, Deutschland

    Claudia Mehler-Wex

  3. Kinder- und Jugendpsychiatrischer Dienst des Kantons Zürich, Zürich, Schweiz

    Susanne Walitza

  4. Kliniken der Stadt Köln, Klinik für Kinder- und Jugendpsychiatrie und Psychotherapie, Köln, Deutschland

    Christoph Wewetzer

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag/Wien

About this chapter

Cite this chapter

Romanos, M., Kerdar, M.S., Renner, T., Gerlach, M. (2009). Antiepileptika (Antikonvulsiva). In: Gerlach, M., Warnke, A., Mehler-Wex, C., Walitza, S., Wewetzer, C. (eds) Neuro-Psychopharmaka im Kindes- und Jugendalter. Springer, Vienna. https://doi.org/10.1007/978-3-211-79275-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-211-79275-9_7

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-79274-2

  • Online ISBN: 978-3-211-79275-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation